Efficacy of 2% ganciclovir eye drops in the treatment of cytomegalovirus anterior uveitis
This study's findings suggest that 2% GCV eye drops are a safe and effective treatment option for primary CMV-AU, offering improvements in IOP and uveitis control. All the patients completed the treatment without serious adverse events, supporting the favorable safety profile of 2% GCV eye drops.
Authors
- Keisuke Yoneda (ORCID: https://orcid.org/0000-0002-3247-7001)
- Kyosuke Seki
- Takeru Oyama (ORCID: https://orcid.org/0000-0002-8161-6573)
- Yuki Takenaka
- Yu Yoneda
- N. Taniguchi (ORCID: https://orcid.org/0000-0002-1462-0564)
- Masaru Takeuchi (ORCID: https://orcid.org/0000-0002-4913-7089)
- Masaya Imazeki
Institutions
- National Defense Medical College (JP)
Publication Details
- Journal
- Japanese Journal of Ophthalmology
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1007/s10384-025-01250-y
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Defense Medical College
- Japan Society for the Promotion of Science